to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.
KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures.
Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report.
Tumor Mutation Burden-From Doubts to Concerns-In Reply.
TMB or not TMB as a biomarker: That is the question.
Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma.
Tumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy.
Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.
Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs.
Tumor Mutation Burden-From Hopes to Doubts.
Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic.
Measuring tumor mutation burden in cell-free DNA: advantages and limits.
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.